Corbus Pharmaceuticals Holdings, Inc. Research and Development Expense
Corbus Pharmaceuticals Holdings, Inc. (CRBP) reported Research and Development Expense of $31.18 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-06
- Corbus Pharmaceuticals Holdings, Inc. research and development expense for the quarter ending 2026-06-30 was $31.18M, a 105.27% increase year-over-year.
- Corbus Pharmaceuticals Holdings, Inc. research and development expense for the quarter ending 2026-03-31 was $19.82M, a 26.70% increase year-over-year.
- Corbus Pharmaceuticals Holdings, Inc. research and development expense for the quarter ending 2025-12-31 was $18.41M, a 109.47% increase year-over-year.
- Corbus Pharmaceuticals Holdings, Inc. research and development expense for the quarter ending 2025-09-30 was $20.86M, a 93.01% increase year-over-year.
- Corbus Pharmaceuticals Holdings, Inc. research and development expense for fiscal 2025 was $70.09M, a 117.54% increase from fiscal 2024.
- Corbus Pharmaceuticals Holdings, Inc. research and development expense for fiscal 2024 was $32.22M, a 3.38% increase from fiscal 2023.
- Corbus Pharmaceuticals Holdings, Inc. research and development expense for fiscal 2023 was $31.17M, a 93.15% increase from fiscal 2022.
- Corbus Pharmaceuticals Holdings, Inc. research and development expense for fiscal 2022 was $16.14M, a 55.72% decline from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $31.18M 10-Q · filed 2026-08-06 | $50.99M 10-Q · filed 2026-08-06 | $69.40M derived: sum of 3 quarters · filed 2026-08-06 | $90.26M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $19.82M 10-Q · filed 2026-05-12 | $38.23M derived: sum of 2 quarters · filed 2026-05-12 | $59.09M derived: sum of 3 quarters · filed 2026-05-12 | $74.27M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $18.41M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $39.27M derived: sum of 2 quarters · filed 2026-03-09 | $54.45M derived: sum of 3 quarters · filed 2026-08-06 | $70.09M 10-K · filed 2026-03-09 | ||||
| 2025-09-30 | $20.86M 10-Q · filed 2025-11-12 | $36.05M derived: sum of 2 quarters · filed 2026-08-06 | $51.69M 10-Q · filed 2025-11-12 | $60.48M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $15.19M 10-Q · filed 2026-08-06 | $30.83M 10-Q · filed 2026-08-06 | $39.62M derived: sum of 3 quarters · filed 2026-08-06 | $50.42M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $15.64M 10-Q · filed 2026-05-12 | $24.43M derived: sum of 2 quarters · filed 2026-05-12 | $35.24M derived: sum of 3 quarters · filed 2026-05-12 | $42.10M derived: sum of 4 quarters · filed 2026-05-12 | ||||
| 2024-12-31 | $8.79M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $19.59M derived: sum of 2 quarters · filed 2026-03-09 | $26.46M derived: sum of 3 quarters · filed 2026-03-09 | $32.22M 10-K · filed 2026-03-09 | ||||
| 2024-09-30 | $10.81M 10-Q · filed 2025-11-12 | $17.67M derived: sum of 2 quarters · filed 2025-11-12 | $23.43M 10-Q · filed 2025-11-12 | $30.41M derived: sum of 4 quarters · filed 2025-11-12 | ||||
| 2024-06-30 | $6.87M 10-Q · filed 2025-08-05 | $12.63M 10-Q · filed 2025-08-05 | $19.61M derived: sum of 3 quarters · filed 2025-08-05 | $26.16M derived: sum of 4 quarters · filed 2025-08-05 | ||||
| 2024-03-31 | $5.76M 10-Q · filed 2025-05-06 | $5.76M 10-Q · filed 2024-05-07 | $12.74M derived: sum of 2 quarters · filed 2025-05-06 | $19.29M derived: sum of 3 quarters · filed 2025-05-06 | $23.54M derived: sum of 4 quarters · filed 2025-05-06 | |||
| 2023-12-31 | $6.98M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $13.53M derived: sum of 2 quarters · filed 2025-03-11 | $17.78M derived: sum of 3 quarters · filed 2025-03-11 | $31.17M 10-K · filed 2025-03-11 | $31.17M 10-K · filed 2024-03-12 | |||
| 2023-09-30 | $6.55M 10-Q · filed 2024-11-07 | $6.55M 10-Q · filed 2023-11-07 | $10.80M derived: sum of 2 quarters · filed 2024-11-07 | $24.19M 10-Q · filed 2024-11-07 | $24.19M 10-Q · filed 2023-11-07 | $30.43M derived: sum of 4 quarters · filed 2024-11-07 | ||
| 2023-06-30 | $4.25M 10-Q · filed 2024-08-06 | $4.25M 10-Q · filed 2023-08-08 | $17.64M 10-Q · filed 2024-08-06 | $17.64M 10-Q · filed 2023-08-08 | $23.88M derived: sum of 3 quarters · filed 2024-08-06 | $27.99M derived: sum of 4 quarters · filed 2024-08-06 | ||
| 2023-03-31 | $13.39M 10-Q · filed 2024-05-07 | $19.63M derived: sum of 2 quarters · filed 2024-05-07 | $23.74M derived: sum of 3 quarters · filed 2024-05-07 | $26.24M derived: sum of 4 quarters · filed 2024-05-07 | ||||
| 2022-12-31 | $6.24M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | $10.35M derived: sum of 2 quarters · filed 2024-03-12 | $12.85M derived: sum of 3 quarters · filed 2024-03-12 | $16.14M 10-K · filed 2024-03-12 | ||||
| 2022-09-30 | $4.11M 10-Q · filed 2023-11-07 | $6.61M derived: sum of 2 quarters · filed 2023-11-07 | $9.89M 10-Q · filed 2023-11-07 | $10.27M derived: sum of 4 quarters · filed 2023-11-07 | ||||
| 2022-06-30 | $2.50M 10-Q · filed 2023-08-08 | $5.79M 10-Q · filed 2023-08-08 | $6.17M derived: sum of 3 quarters · filed 2023-08-08 | $14.86M derived: sum of 4 quarters · filed 2023-08-08 | ||||
| 2022-03-31 | $3.29M 10-Q · filed 2023-05-09 | $3.67M derived: sum of 2 quarters · filed 2023-05-09 | $12.36M derived: sum of 3 quarters · filed 2023-05-09 | $23.63M derived: sum of 4 quarters · filed 2023-05-09 | ||||
| 2021-12-31 | $380.00K 10-Q · filed 2022-11-08 | $9.08M derived: sum of 2 quarters · filed 2022-11-08 | $20.34M derived: sum of 3 quarters · filed 2022-11-08 | $36.45M 10-K · filed 2023-03-07 | ||||
| 2021-09-30 | $8.70M 10-Q · filed 2022-11-08 | $19.96M derived: sum of 2 quarters · filed 2022-11-08 | $30.68M 10-Q · filed 2022-11-08 | $46.79M derived: sum of 4 quarters · filed 2022-11-08 | ||||
| 2021-06-30 | $11.27M 10-Q · filed 2022-08-09 | $21.99M 10-Q · filed 2022-08-09 | $38.10M derived: sum of 3 quarters · filed 2022-08-09 | $65.62M derived: sum of 4 quarters · filed 2022-08-09 | ||||
| 2021-03-31 | $10.72M 10-Q · filed 2022-05-10 | $26.83M derived: sum of 2 quarters · filed 2022-05-10 | $54.35M derived: sum of 3 quarters · filed 2022-05-10 | $85.04M derived: sum of 4 quarters · filed 2022-05-10 | ||||
| 2020-12-31 | $16.11M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | $43.63M derived: sum of 2 quarters · filed 2022-03-08 | $74.32M derived: sum of 3 quarters · filed 2022-03-08 | $98.27M 10-K · filed 2022-03-08 | ||||
| 2020-09-30 | $27.52M 10-Q · filed 2021-11-12 | $58.21M derived: sum of 2 quarters · filed 2021-11-12 | $82.16M 10-Q · filed 2021-11-12 | $105.64M derived: sum of 4 quarters · filed 2021-11-12 | ||||
| 2020-06-30 | $30.69M 10-Q · filed 2021-08-12 | $54.63M 10-Q · filed 2021-08-12 | $78.12M derived: sum of 3 quarters · filed 2021-08-12 | $100.27M derived: sum of 4 quarters · filed 2021-08-12 | ||||
| 2020-03-31 | $23.95M 10-Q · filed 2021-05-13 | $47.44M derived: sum of 2 quarters · filed 2021-05-13 | $69.59M derived: sum of 3 quarters · filed 2021-05-13 | $91.77M derived: sum of 4 quarters · filed 2021-05-13 | ||||
| 2019-12-31 | $23.49M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $45.64M derived: sum of 2 quarters · filed 2021-03-15 | $67.82M derived: sum of 3 quarters · filed 2021-03-15 | $89.60M 10-K · filed 2021-03-15 | ||||
| 2019-09-30 | $22.15M 10-Q · filed 2020-11-09 | $44.33M derived: sum of 2 quarters · filed 2020-11-09 | $66.12M 10-Q · filed 2020-11-09 | $81.90M derived: sum of 4 quarters · filed 2020-11-09 | ||||
| 2019-06-30 | $22.18M 10-Q/A · filed 2020-08-31 | $43.97M 10-Q/A · filed 2020-08-31 | $59.75M derived: sum of 3 quarters · filed 2020-08-31 | $72.55M derived: sum of 4 quarters · filed 2020-08-31 | ||||
| 2019-03-31 | $21.78M 10-Q · filed 2020-05-11 | $37.56M derived: sum of 2 quarters · filed 2020-05-11 | $50.37M derived: sum of 3 quarters · filed 2020-05-11 | $60.63M derived: sum of 4 quarters · filed 2020-05-11 | ||||
| 2018-12-31 | $15.78M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $28.59M derived: sum of 2 quarters · filed 2020-03-16 | $38.85M derived: sum of 3 quarters · filed 2020-03-16 | $48.61M 10-K · filed 2020-03-16 | ||||
| 2018-09-30 | $12.81M 10-Q · filed 2019-11-07 | $23.07M derived: sum of 2 quarters · filed 2019-11-07 | $32.83M 10-Q · filed 2019-11-07 | $41.12M derived: sum of 4 quarters · filed 2019-11-07 | ||||
| 2018-06-30 | $10.26M 10-Q · filed 2019-08-08 | $20.03M 10-Q · filed 2019-08-08 | $28.31M derived: sum of 3 quarters · filed 2019-08-08 | $33.93M derived: sum of 4 quarters · filed 2019-08-08 | ||||
| 2018-03-31 | $9.77M 10-Q · filed 2019-05-09 | $18.05M derived: sum of 2 quarters · filed 2019-05-09 | $23.67M derived: sum of 3 quarters · filed 2019-05-09 | $29.44M derived: sum of 4 quarters · filed 2019-05-09 | ||||
| 2017-12-31 | $8.29M 10-K · filed 2018-03-12 | $13.91M derived: sum of 2 quarters · filed 2018-11-08 | $19.67M derived: sum of 3 quarters · filed 2018-11-08 | $26.04M 10-K · filed 2019-03-12 | ||||
| 2017-09-30 | $5.62M 10-Q · filed 2018-11-08 | $11.39M derived: sum of 2 quarters · filed 2018-11-08 | $17.75M 10-Q · filed 2018-11-08 | $23.13M derived: sum of 4 quarters · filed 2018-11-08 | ||||
| 2017-06-30 | $5.76M 10-Q · filed 2018-08-08 | $12.13M 10-Q · filed 2018-08-08 | $17.51M derived: sum of 3 quarters · filed 2018-08-08 | $21.83M derived: sum of 4 quarters · filed 2018-08-08 | ||||
| 2017-03-31 | $6.37M 10-K · filed 2018-03-12 | $11.75M derived: sum of 2 quarters · filed 2018-05-10 | $16.06M derived: sum of 3 quarters · filed 2018-05-10 | $19.63M derived: sum of 4 quarters · filed 2018-05-10 | ||||
| 2016-12-31 | $5.38M 10-K · filed 2018-03-12 | $9.70M derived: sum of 2 quarters · filed 2018-03-12 | $13.26M derived: sum of 3 quarters · filed 2018-03-12 | $15.44M 10-K · filed 2018-03-12 | ||||
| 2016-09-30 | $4.32M 10-K · filed 2018-03-12 | $7.88M derived: sum of 2 quarters · filed 2018-03-12 | $10.06M 10-Q · filed 2017-11-08 | $11.88M derived: sum of 4 quarters · filed 2018-03-12 | ||||
| 2016-06-30 | $3.57M 10-K · filed 2018-03-12 | $5.74M 10-Q · filed 2017-08-09 | $7.56M derived: sum of 3 quarters · filed 2018-03-12 | $9.20M derived: sum of 4 quarters · filed 2018-03-12 | ||||
| 2016-03-31 | $2.17M 10-K · filed 2018-03-12 | $4.00M derived: sum of 2 quarters · filed 2018-03-12 | $5.63M derived: sum of 3 quarters · filed 2018-03-12 | $7.34M derived: sum of 4 quarters · filed 2018-03-12 | ||||
| 2015-12-31 | $1.82M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | $3.46M derived: sum of 2 quarters · filed 2018-03-12 | $5.17M derived: sum of 3 quarters · filed 2018-03-12 | $5.89M 10-K · filed 2018-03-12 | ||||
| 2015-09-30 | $1.63M 10-Q · filed 2016-11-10 | $3.34M derived: sum of 2 quarters · filed 2016-11-10 | $4.07M 10-Q · filed 2016-11-10 | $4.64M derived: sum of 4 quarters · filed 2016-11-10 | ||||
| 2015-06-30 | $1.71M 10-Q · filed 2016-08-12 | $2.43M 10-Q · filed 2016-08-12 | $3.00M derived: sum of 3 quarters · filed 2016-08-12 | $3.45M derived: sum of 4 quarters · filed 2016-08-12 | ||||
| 2015-03-31 | $723.43K 10-Q · filed 2016-05-13 | $1.30M derived: sum of 2 quarters · filed 2016-05-13 | $1.75M derived: sum of 3 quarters · filed 2016-05-13 | $1.92M derived: sum of 4 quarters · filed 2016-05-13 | ||||
| 2014-12-31 | $571.58K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-28 | $1.02M derived: sum of 2 quarters · filed 2016-03-28 | $1.19M derived: sum of 3 quarters · filed 2016-03-28 | $1.26M 10-K · filed 2016-03-28 | ||||
| 2014-09-30 | $452.60K 10-Q · filed 2015-11-10 | $622.04K derived: sum of 2 quarters · filed 2015-11-10 | $683.96K 10-Q · filed 2015-11-10 | $668.71K derived: sum of 4 quarters · filed 2015-11-10 | ||||
| 2014-06-30 | $169.44K 10-Q · filed 2015-08-13 | $231.36K 10-Q · filed 2015-08-13 | $216.11K derived: sum of 3 quarters · filed 2015-08-13 | $245.08K derived: sum of 4 quarters · filed 2015-08-13 | ||||
| 2014-03-31 | $61.92K 10-Q · filed 2015-05-13 | $46.66K derived: sum of 2 quarters · filed 2015-05-13 | $75.64K derived: sum of 3 quarters · filed 2015-05-13 | |||||
| 2013-12-31 | -$15.25K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-10 | $13.72K derived: sum of 2 quarters · filed 2015-02-10 | $210.67K 10-K · filed 2015-02-10 | |||||
| 2013-09-30 | $28.97K 10-Q · filed 2014-11-13 | $225.92K 10-Q · filed 2014-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |